Radio Advisory

For decades Alzheimer's research was centered around one theory, the amyloid-beta hypothesis. That theory is now being called into question after evidence of potential fraud. In this episode, Rachel (Rae) woods invites life sciences expert Nick Hula and senior care expert Miriam Sznycer-Taub to talk about what this means for the scientific and medical community, how to restore trust in medical res...

One of the biggest challenges healthcare leaders are grappling with is the workforce shortage, particularly in nursing. This isn’t a new problem, so why haven't we found real solutions? Host Rachel (Rae) Woods invites Henry Ford Health System's Vice President and Chief Innovation Officer Lisa Prasad and Senior Vice President and Chief Nursing Officer Eric Wallis to discuss why we need to look at t...

Celebrity entrepreneur Mark Cuban wants to make buying drugs less complicated and more affordable, and an online pharmacy he recently invested in aims to do just that. So how does this work, and is it enough to solve the drug pricing problem in America? Host Rachel (Rae) Woods talks with pharmacy experts Gina Lohr and Chloe Bakst about this business model and drug pricing reforms in the recently p...

Radio Advisory is rounding out its healthcare disruptor series with an episode about possibly the biggest disruptor of all – Amazon. Their acquisition of One Medical is among the biggest investments in care delivery by a non-healthcare entity. The acquisition has kicked off an arms race for physicians, with organizations like CVS announcing their own massive deals. In this episode, Rachel (Rae) Wo...

(New/bonus content starts at 22:09. First part of episode originally aired November 2, 2021.) There's been plenty of talk about companies being disruptive in the healthcare industry, from Amazon to Walmart, but a company you might not be thinking about is also making moves into the healthcare world—Best Buy. In this episode, host Rachel Woods sits down with Advisory Board's Miriam Sznycer-Taub to...

This episode was recorded on August 5, 2022. In part two of Radio Advisory’s disruptor series, Rachel (Rae) Woods invites Walgreens Health Chief Clinical Officer Dr. Sashi Moodley to discuss the obstacles of being a disruptor in a crowded competitive field, building longitudinal relationships with patients instead of transactional, and Walgreens’s goal of becoming an equal player in the value-base...

It seems like we’re always hearing about new disruptors and competitors aiming to shake up the way healthcare is designed, delivered, and paid for. Perhaps the most notable are the retail disruptors, like Walgreens Health or CVS Health. But how do you know if something is a potential threat that could have a real impact on your business? In this episode, Rachel (Rae) Woods invites healthcare strat...

Buzzwords and phrases like “equity”, “digital divide”, and “cultural competency” are used often health care. However, there’s no real consensus on their actual definitions, and that can be problematic. In this episode, host Rachel (Rae) Woods talks with value-based care expert Daniel Kuzmanovich and health equity researcher Darby Sullivan to discuss why language has never been more important in th...

During the peak of the pandemic an estimated 9.4 million cancer screenings were missed – which we know led to delayed cancer diagnoses. In this episode, Rachel (Rae) Woods invites oncology experts Ashley Riley and Lauren Woodrow to discuss both the human and system-wide impacts of delayed cancer screenings and what health leaders can do to rebound. Links: Early data shows a rise in advanced cancer...

New policies and heightened competition are making payers re-consider their identities and roles in the health care industry. In this episode, Rachel (Rae) Woods invites health plan experts Mallory Kirby and Sally Kim to talk about why payers are positioning themselves as health solutions companies, the strategic moves in play, and why diversification may be necessary for survival. Radio Advisory...

(New/bonus content starts at 19:11. First part of episode originally aired June 7, 2022.) Medicare is slowly moving forward on risk, but commercial risk is more of a wild card and the health care industry has yet to land on a clear model for the population. In this episode, Rachel Woods sits down with Advisory Board's Clare Wirth and Alex Tallian to discuss their research into commercial risk and...

It's no secret that health care is facing a workforce crisis. The good news is that workers aren't leaving the industry entirely, but instead moving on to other roles that enhance their quality of life – and it's not just about the money. In this episode, Rachel (Rae) Woods invites health care workforce experts Eliza Dailey , Monica Westhead , and Alex Polyak to discuss workplace qualities that ha...

Advisory Board’s State of the Industry report gives healthcare leaders a view of what's happening around them and how various trends, actions, and forces will shape the industry's future. In this episode Rachel (Rae) Woods sits down with healthcare experts Ashley Antonelli and Natalie Trebes to talk about how the economy, workforce shortages, and policy shifts are impacting the industry and how he...

Private equity tends to get a bad rap when it comes to healthcare. Some see it as a disruptive force that prioritizes profits over the patient experience, and that it’s hurting the industry by creating a more consolidated marketplace. Others, however see it as an opportunity for innovation, growth, and more movement towards value-based care. In this episode, Rachel (Rae) Woods invites Advisory Boa...

U.S. health care has made some strides in making behavioral health treatment more accessible by pouring more money into services like telebehavioral health. So why are we still seeing significant increases in mental health conditions and drug overdose deaths? Are we putting our money in the right places? In this episode Rachel (Rae) Woods invites Advisory Board’s Darby Sullivan and Rachel Zuckerma...

Rae invites Advisory Board experts to share their perspective on the biggest impact that overturning Roe v. Wade will have on providers, purchasers, and life sciences companies. Plus, experts share what they are watching for as the health care industry adapts to a post-Roe reality. Links: The business implications of overturning Roe v. Wade Ep. 116: The ripple effects of overturning Roe v. Wade Ro...

In early May, CMS released the inpatient prospective payment system proposed rule for fiscal year 2023. In this year’s proposal CMS introduced several policies aimed at addressing health equity. Among those is a data collection condition that would require a provider to attest that their organization is capturing SDOH measures. Eric Fontana, Vice President of Client Solutions at Optum Life Science...

We know that climate change is a public health problem – and now, health care leaders are getting a better understanding of how their own organizations are contributing to the problem. In this episode, Rachel Woods sits down with Advisory Board's Miles Cottier to discuss the state of the climate change problem and why health care leaders shouldn’t wait for government action to start making progres...

Medicare is slowly moving forward on risk, but commercial risk is more of a wild card and the health care industry has yet to land on a clear model for the population. In this episode, Rachel Woods sits down with Advisory Board's Clare Wirth and Alex Tallian to discuss their research into commercial risk and why they believe commercial risk is possible for the health care industry. Links: Our Valu...

There have been plenty of headlines sounding the alarm over a physician shortage, but how valid are those concerns? In this episode, Rachel Woods sits down with Advisory Board's Daniel Kuzmanovich and Sebastian Beckmann to talk about the existence of a physician shortage and the solutions health care leaders can take to prevent one. Links: How to prevent a primary care shortage The Medical Group L...

Regardless of moral, religious, or ethical opinion, abortion is a health care procedure, and changes to the accessibility and legality of that procedure will have implications nationwide. In this episode, Rachel Woods sits down with Rebecca Willman, membership director of Abortion Care Network, to talk about the clinical and operational ramifications the leaked draft opinion in Dobbs v. Jackson Wo...

It's Nurses Month, which means there are a lot of conversations being had right now about the nursing profession, and most of them involve the word crisis. In this episode, Rachel Woods has a different type of conversation about nursing and sits down with Advisory Board's Carol Boston-Fleischhauer and Lauren Rewers to talk about how health care leaders can bring joy back to nursing. Links: View ou...

The life sciences part of health care isn't just drugmakers and medical device companies—data and evidence coming from life sciences is critical to the entire health care ecosystem. In this episode, Rachel Woods sits down with Advisory Board's Solomon Banjo and Pam Divack, and SVP of Optum Life Sciences Lou Brooks, to talk about the evolving role of evidence and how evidence impacts all parts of t...

Value-based care and risk-based payment are two things on the forefront of everyone's mind in the health care industry, but is the industry read to move forward towards meaningful risk? In this episode, Rachel Woods sits down with Advisory Board's Daniel Kuzmanovich and Clare Wirth to talk about what it will take for the health care industry to move towards meaningful risk, the biggest concerns le...

There's a lot of buzz about digital health right now, with many organizations wanting to get their piece of the digital health pie, but what is the end goal of digital transformation? In this episode, host Rachel Woods sits down with Advisory Board's John League to talk about what digital health actually means and what the goals behind it are. Links: 2 things my dad taught me about digital health—...